explore -WSS

explore

author：knowledge 2025-10-02 00:27:52 - browse：26

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： FDA panel to weigh safety of artificial wombs for preterm births

WSS

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

In same hospitals, Black patients receive fewer opioids than white patients

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Why failed clinical trials don’t always spell doom for a new drug

'A game

South Korea throws huge K

explore

explore

Wikipedia

What does generative AI mean for health care? We asked experts

Wegovy trial has doctors encouraged over new possibilities

Psychedelics group wrestles with new pharma identity

Assistant physicians can help address the primary care shortage

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Hepatitis C has a cure — but many Americans still lack access to it

South Korea throws huge K

Dobbs anniversary: the lost opportunity of abortion as health care

NIH trials fail to test meaningful long Covid therapies, experts say

Wikipedia

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Police still searching for prisoner who escaped from NYC hospital

The unintended consequences of overturning Roe v. Wade

People with substance use disorder deserve online privacy

Naloxone nonprofit donates 200,000 doses after FDA approval

Friends ask where James Watson's attitudes about race came from

explore

focus

hotspot

hotspot